Personal health records as portal to the electronic medical record Jennifer E. CahillMark R. GilbertTerri S. Armstrong Topic Review 30 January 2014 Pages: 1 - 6
PI3K pathway inhibitors for the treatment of brain metastases with a focus on HER2+ breast cancer Parvin F. PeddiSara A. Hurvitz Topic Review 28 January 2014 Pages: 7 - 13
Detection of primary cilia in human glioblastoma Matthew R. SarkisianDorit SiebzehnrublBrent A. Reynolds Laboratory Investigation 09 February 2014 Pages: 15 - 24
NDRG1 prognosticates the natural course of disease in WHO grade II glioma J. BlaesM. WeilerW. Wick Laboratory Investigation 07 January 2014 Pages: 25 - 32
Radiologic and histologic consequences of radiosurgery for brain tumors Ahmed AlomariPhilipp J. RauchAlexander O. Vortmeyer Laboratory Investigation 18 January 2014 Pages: 33 - 42
CXCL12 secreted from glioma stem cells regulates their proliferation Youji UemaeEiichi IshikawaAkira Matsumura Laboratory Investigation 19 January 2014 Pages: 43 - 51
C-terminally truncated form of αB-crystallin is associated with IDH1 R132H mutation in anaplastic astrocytoma Nuraly K. AvliyakulovKavitha S. RajavelWhitney B. Pope Laboratory Investigation 29 January 2014 Pages: 53 - 65
Prognostic significance of telomere maintenance mechanisms in pediatric high-grade gliomas Kathleen DorrisMatthew SoboRachid Drissi Laboratory Investigation 30 January 2014 Pages: 67 - 76
Neoadjuvant cisplatin plus temozolomide versus standard treatment in patients with unresectable glioblastoma or anaplastic astrocytoma: a differential effect of MGMT methylation Laia CapdevilaSara CrosCarmen Balañà Clinical Study 07 January 2014 Pages: 77 - 84
Towards optimizing the sequence of bevacizumab and nitrosoureas in recurrent malignant glioma Benedikt WiestlerAlexander RadbruchAntje Wick Clinical Study 24 January 2014 Pages: 85 - 92
A phase II trial of PTK787/ZK 222584 in recurrent or progressive radiation and surgery refractory meningiomas Jeffrey J. RaizerSean A. GrimmMarc Chamberlain Clinical Study 22 January 2014 Pages: 93 - 101
Patterns of care at end of life for people with primary intracranial tumors: lessons learned Abdulrahman AlturkiBruno GagnonNancy Mayo Clinical Study 28 January 2014 Pages: 103 - 115
CSF CA 15-3 in breast cancer-related leptomeningeal metastases Emilie Le RhunAndrew KramarMarc C. Chamberlain Clinical Study 28 January 2014 Pages: 117 - 124
Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme Colin E. ChampJoshua D. PalmerWenyin Shi Clinical Study 19 January 2014 Pages: 125 - 131
Large volume reirradiation as salvage therapy for glioblastoma after progression on bevacizumab William MagnusonH. Ian RobinsSteven Howard Clinical Study 28 January 2014 Pages: 133 - 139
Cilengitide treatment of newly diagnosed glioblastoma patients does not alter patterns of progression Günter EiseleAntje WickMichael Weller Clinical Study 19 January 2014 Pages: 141 - 145
Factors impacting survival following second surgery in patients with glioblastoma in the temozolomide treatment era, incorporating neutrophil/lymphocyte ratio and time to first progression Mairéad G. McNamaraZarnie LwinWarren P. Mason Clinical Study 28 January 2014 Pages: 147 - 152
Conditional probability of survival and post-progression survival in patients with glioblastoma in the temozolomide treatment era Mairéad G. McNamaraZarnie LwinWarren P. Mason Clinical Study 29 January 2014 Pages: 153 - 160
Methotrexate re-challenge for recurrent primary central nervous system lymphoma Elena PentsovaLisa M. DeAngelisAntonio Omuro Clinical Study 31 January 2014 Pages: 161 - 165
Local control and toxicity outcomes in brainstem metastases treated with single fraction radiosurgery: is there a volume threshold for toxicity? Jeremy M. KilburnThomas L. EllisMichael D. Chan Clinical Study 07 February 2014 Pages: 167 - 174
Diffusion-weighted MRI derived apparent diffusion coefficient identifies prognostically distinct subgroups of pediatric diffuse intrinsic pontine glioma Robert M. LoberYoon-Jae ChoKristen W. Yeom Clinical Study 13 February 2014 Pages: 175 - 182
High expression of the stem cell marker nestin is an adverse prognostic factor in WHO grade II–III astrocytomas and oligoastrocytomas Kimmo J. HatanpaaTianshen HuRobert M. Bachoo Clinical Study 12 February 2014 Pages: 183 - 189
Detecting post-surgical recurrence in a patient with Cushing’s disease Kelley J. MoloneyJennifer U. MercadoMarc R. Mayberg Letter to the Editor Open access 12 February 2014 Pages: 191 - 193
The Neutrophil Lymphocyte Ratio in Patients with Glioblastoma Multiforme Sevket BaltaSait DemirkolCengiz Ozturk Letter to the Editor 10 January 2014 Pages: 195 - 196